With low ovarian reserve, Highly Individualized Egg Retrieval (HIER) improves IVF results by avoiding premature luteinization.

Abstract:

BACKGROUND:Highly Individualized Egg Retrieval (HIER), defined as age-specific early oocyte retrieval (ER), has been demonstrated to avoid premature luteinization in women ≥43. We here investigated whether HIER also applies to younger women with premature ovarian aging (POA), and what best lead follicle size should be for administration of ovulation-triggers. METHODS:Fifty-six women ≥43, and 37 POA patients underwent IVF cycles. Granulosa cells (GCs) were isolated, cultures were established, RNA was extracted and real-time PCR analyses performed, with gene expressions at mRNA level investigated for FSH receptor (FSHR), luteinizing hormone receptor (LHCPR), P450 aromatase (CYP19a1) and progesterone receptor (PGR). POA was defined by age < 40, FSH above 95%CI and/or AMH below 95%CI for age. Women ≥43 years were divided into very early retrieval (VER), with human chorionic gonadotropin (hCG) trigger at 13.5-15.5 mm, ER at 16.0-18.0 mm or standard retrievel (SR) at 18.5-20.5 mm; POA patients were divided into ER and SR. Pregnancy rates and and molecular markers of premature luteinization (PL) were main outcome measures. RESULTS:ER resulted in a significantly higher clinical pregnancy rate (16.7%) than VER (5.9%) or SR (6.7%; both P < 0.05). Molecular markers of PL were highest with SR and lowest with VER. In POA, ER improved pregnancy chances even more than in women ≥43 (7.7% with SR vs. 41.7% with ER), while also reducing molecular markers of PL. With low ovarian reserve (LOR), by avoiding PL, ER with hCG trigger at 16.0-18.0 mm, thus, improves clinical pregnancy rates at all ages. As VER demonstrated lowest molecular PL marker but equally poor pregnancy rates as SR, too early ovulation triggers, likely, result in cytoplasmatic immaturity. CONCLUSIONS:HIER is even more effective in POA patients than women above age 43, demonstrating that HIER should be further investigated going into even more advanced ages.

journal_name

J Ovarian Res

authors

Wu YG,Barad DH,Kushnir VA,Wang Q,Zhang L,Darmon SK,Albertini DF,Gleicher N

doi

10.1186/s13048-018-0398-8

subject

Has Abstract

pub_date

2018-03-16 00:00:00

pages

23

issue

1

issn

1757-2215

pii

10.1186/s13048-018-0398-8

journal_volume

11

pub_type

杂志文章
  • Development of a multi-gene-based immune prognostic signature in ovarian Cancer.

    abstract:BACKGROUND:Various components of the immune system play a critical role in the prognosis and treatment response in ovarian cancer (OC). Immunotherapy has been recognized as a hallmark of cancer but the effect is contradictional. Reliable immune gene-based prognostic biomarkers or regulatory factors are necessary to be ...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-021-00766-4

    authors: Cao T,Shen H

    更新日期:2021-01-28 00:00:00

  • Evaluation of primary adnexal masses by 3T MRI: categorization with conventional MR imaging and diffusion-weighted imaging.

    abstract:UNLABELLED: BACKGROUND:To investigate the 3.0-Tesla (3 T) magnetic resonance imaging (MRI) characteristics of primary adnexal lesions for discriminating benign from malignant lesions. METHODS:One hundred thirty-nine patients with pathologically proven primary adnexal masses referred for 3 T MRI assessment preoperativ...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/1757-2215-5-33

    authors: Zhang H,Zhang GF,He ZY,Li ZY,Zhu M,Zhang GX

    更新日期:2012-11-14 00:00:00

  • Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival.

    abstract:BACKGROUND:Altered androgen hormone homeostasis and androgen receptor (AR) activity have been implicated in ovarian carcinogenesis but the relationship between AR expression in ovarian cancer and clinical outcome remains unclear. METHODS:In this study, the prognostic impact of AR expression was investigated using immu...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/1757-2215-3-14

    authors: Nodin B,Zendehrokh N,Brändstedt J,Nilsson E,Manjer J,Brennan DJ,Jirström K

    更新日期:2010-06-17 00:00:00

  • The clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancer.

    abstract:BACKGROUND:We aimed to examine the expression of miR-1307 in chemosensitive and chemoresistant epithelial ovarian cancer tissues and cell lines and to analyze the clinicopathological significance of miR-1307 in ovarian cancer. METHODS:MicroRNA microarray was used to screen differentially expressed microRNAs between th...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-015-0143-5

    authors: Zhou Y,Wang M,Wu J,Jie Z,Chang S,Shuang T

    更新日期:2015-04-09 00:00:00

  • Lnc-GULP1-2:1 affects granulosa cell proliferation by regulating COL3A1 expression and localization.

    abstract:BACKGROUNDS:Long non-coding RNA is a novel group of non-protein coding transcripts over 200 nt in length. Recent studies have found that they are widely involved in many pathological and physiological processes. In our previous study, we found that lnc-GULP1-2:1 was significantly down-regulated in the ovarian cortical ...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-021-00769-1

    authors: Yao G,Kong Y,Yang G,Kong D,Xu Y,He J,Xu Z,Bai Y,Fan H,He Q,Sun Y

    更新日期:2021-01-20 00:00:00

  • MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1.

    abstract:BACKGROUND:Epithelial ovarian cancer (EOC) is still a major gynecologic problem with poor 5 year survival rate due to distance metastases, despite routine surgery and chemotherapy. The precise underlying molecular mechanisms that trigger EOC migration and invasion are unclear. Recent studies suggest that the expression...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/1757-2215-6-84

    authors: Zhang H,Wang Q,Zhao Q,Di W

    更新日期:2013-11-26 00:00:00

  • Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer.

    abstract:BACKGROUND:Epithelial ovarian cancer has the highest fatality rate of all gynecologic malignancies. Although the majority of patients achieve complete clinical response after initial cytoreductive surgery and platinum-based chemotherapy, most recur and almost all will eventually acquire platinum-resistance for which tr...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-019-0506-4

    authors: Cohen S,Schwartz M,Dottino P,Beddoe AM

    更新日期:2019-04-25 00:00:00

  • Metabolic active peritoneal sites affect tumor debulking in ovarian and peritoneal cancers.

    abstract:RATIONALE AND OBJECTIVES:To evaluate the impact of metabolic parameters in the peritoneal cavity on the likelihood of achieving complete tumor debulking in patients with ovarian and peritoneal cancers. MATERIALS AND METHODS:Forty-nine patients with ovarian and peritoneal cancers were included, who underwent pre-operat...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-020-00662-3

    authors: Tsoi TT,Chiu KWH,Chu MY,Ngan HYS,Lee EYP

    更新日期:2020-05-20 00:00:00

  • Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women.

    abstract:BACKGROUND:Myo-inositol (MI), successfully used in polycystic ovary syndrome (PCOS), was administered with α-LA to exploit its action of favouring the passage of other molecules through biological barriers, and also considering its anti-inflammatory effect. METHODS:PCOS patients, according to the Rotterdam ESHRE-ASRM ...

    journal_title:Journal of ovarian research

    pub_type: 临床试验,杂志文章

    doi:10.1186/s13048-018-0411-2

    authors: Montanino Oliva M,Buonomo G,Calcagno M,Unfer V

    更新日期:2018-05-10 00:00:00

  • Biological effects of combined resveratrol and vitamin D3 on ovarian tissue.

    abstract:BACKGROUND:Resveratrol (3,5,4'-trihydroxy-trans-stilbene) is a natural antioxidant polyphenol able to exert a wide range of biological effect on several tissues. Despite its important beneficial properties, it has a low water solubility, which limits its therapeutic applications in humans. Resveratrol also acts as a ph...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-017-0357-9

    authors: Uberti F,Morsanuto V,Aprile S,Ghirlanda S,Stoppa I,Cochis A,Grosa G,Rimondini L,Molinari C

    更新日期:2017-09-15 00:00:00

  • Outcomes of ovarian transposition in gynaecological cancers; a systematic review and meta-analysis.

    abstract:BACKGROUND:Pelvic irradiation is essential for improving survival in women with pelvic malignancies despite inducing permanent ovarian damage. Ovarian transposition can be performed in premenopausal women in an attempt to preserve ovarian function. As uncertainty occurs over the proportion of women who are likely to be...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章,meta分析,评审

    doi:10.1186/1757-2215-7-69

    authors: Gubbala K,Laios A,Gallos I,Pathiraja P,Haldar K,Ind T

    更新日期:2014-06-25 00:00:00

  • Comparison of quartz vials with polypropylene vials for rapid cryopreservation of human ovarian tissue.

    abstract:BACKGROUND:Because higher survival of follicles during the freezing/thawing procedure improves the quality of cryopreserved tissue reimplanted after oncological therapies, defining an optimal method for human ovarian tissue cryopreservation remains a major issue in this field. One option to improve the cryopreservation...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-016-0268-1

    authors: Scheiner D,Bracone G,Imesch P,Fink D,Hehl J,Imthurn B

    更新日期:2016-09-26 00:00:00

  • Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical tri

    abstract:BACKGROUND:Ovarian hyperstimulation syndrome remains a serious complication during in vitro fertilization cycles if high dose human chorionic gonadotropin (hCG) is used to trigger ovulation in high responder patients. Though much of this risk is mitigated with trigger using gonadotropin releasing-hormone (GnRH) agonist...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s13048-019-0483-7

    authors: Engmann LL,Maslow BS,Kaye LA,Griffin DW,DiLuigi AJ,Schmidt DW,Grow DR,Nulsen JC,Benadiva CA

    更新日期:2019-01-26 00:00:00

  • The expression of the Sprouty 1 protein inversely correlates with growth, proliferation, migration and invasion of ovarian cancer cells.

    abstract:BACKGROUND:Our recent study on a panel of human ovarian cancer cells revealed that SKOV-3 cells barely express the Sprouty isoform 1 (Spry1) while 1A9 cells maintain it at a level similar to normal ovarian cells. Here we investigated the functional outcomes of induced alterations in the expression of Spry1 in the two c...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/1757-2215-7-61

    authors: Masoumi-Moghaddam S,Amini A,Ehteda A,Wei AQ,Morris DL

    更新日期:2014-06-08 00:00:00

  • Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients.

    abstract:BACKGROUND:Survivin is an inhibitor of apoptosis and a regulator of mitotic progression. TP53 protein is a negative transcriptional regulator of survivin. The aim of our study was to evaluate the clinical significance of survivin expression in advanced stages ovarian cancer with respect to the TP53 status. METHODS:Sur...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/1757-2215-4-20

    authors: Felisiak-Golabek A,Rembiszewska A,Rzepecka IK,Szafron L,Madry R,Murawska M,Napiorkowski T,Sobiczewski P,Osuch B,Kupryjanczyk J,Polish Ovarian Cancer Study Group (POCSG).

    更新日期:2011-11-10 00:00:00

  • Proactive use of PROMs in ovarian cancer survivors: a systematic review.

    abstract:INTRODUCTION:The use of patient reported outcome measures (PROMs) has increased during the past decade, and the focus on how to use them has resulted in a more proactive application. Studies have shown that proactive use of PROMs during treatment improves patient-clinician communication, leads to better symptom managem...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章,评审

    doi:10.1186/s13048-019-0538-9

    authors: Kargo AS,Coulter A,Jensen PT,Steffensen KD

    更新日期:2019-07-15 00:00:00

  • Evidence of metachronous development of ovarian teratomas: a case report of bilateral mature cystic teratomas of the ovaries and systematic literature review.

    abstract:BACKGROUND:Mature cystic teratomas are usually found in the ovaries. They are bilateral in 10 to 15% of cases and multiple cystic teratomas may be present in one ovary. The aim of this study is to clarify if development of mature cystic teratomas of the ovaries in a single host is metachronous or due to autoimplant or ...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章,评审

    doi:10.1186/s13048-017-0313-8

    authors: Wang WC,Lai YC

    更新日期:2017-03-14 00:00:00

  • The aberrant upstream pathway regulations of CDK1 protein were implicated in the proliferation and apoptosis of ovarian cancer cells.

    abstract:BACKGROUND:Upregulation of Cyclin dependent kinase 1 (CDK1) protein is closely related with the prognosis of several malignant tumors. Chk1-CDC25C-CDK1 signaling and P53-P21WAF1-CDK1 signaling pathways are closely related with the cell cycle G2/M phase regulation. The present study aimed to analyze the relationship bet...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-017-0356-x

    authors: Zhang R,Shi H,Ren F,Zhang M,Ji P,Wang W,Liu C

    更新日期:2017-09-12 00:00:00

  • Decreased ovarian function and autophagy gene methylation in aging rats.

    abstract:BACKGROUND:Degeneration of ovarian function is an obvious feature of female aging. In addition, studies have shown that autophagy decreases with age, and DNA methylation is a hallmark epigenetic pattern during aging. However, it is not clear whether the expression and DNA methylation of autophagy genes are involved in ...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-020-0615-0

    authors: Li Q,Cai M,Wang J,Gao Q,Guo X,Jia X,Xu S,Zhu H

    更新日期:2020-02-03 00:00:00

  • FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells.

    abstract:BACKGROUND:Whether there is a mechanistic link between FOLR1 and response to cisplatin has not been extensively examined. In this study, we determine the expression of FOLR1 in ovarian cancer and examine if FOLR1 levels influence response to cisplatin. RESULTS:(1) FOLR1 protein expression was lowest in normal ovarian ...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-018-0387-y

    authors: Huang MJ,Zhang W,Wang Q,Yang ZJ,Liao SB,Li L

    更新日期:2018-02-13 00:00:00

  • SIRT1 activator (SRT1720) improves the follicle reserve and prolongs the ovarian lifespan of diet-induced obesity in female mice via activating SIRT1 and suppressing mTOR signaling.

    abstract:BACKGROUND:The prevalence of obesity is increasing worldwide and significantly affects fertility and reproduction in both men and women. Our recent study has shown that excess body fat accelerates ovarian follicle development and follicle loss in rats. The aim of the present study is to explore the effect of SIRT1 acti...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-014-0097-z

    authors: Zhou XL,Xu JJ,Ni YH,Chen XC,Zhang HX,Zhang XM,Liu WJ,Luo LL,Fu YC

    更新日期:2014-10-21 00:00:00

  • Reliable in vitro studies require appropriate ovarian cancer cell lines.

    abstract::Ovarian cancer is the fifth most common cause of cancer death in women and the leading cause of death from gynaecological malignancies. Of the 75% women diagnosed with locally advanced or disseminated disease, only 30% will survive five years following treatment. This poor prognosis is due to the following reasons: li...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章,评审

    doi:10.1186/1757-2215-7-60

    authors: Jacob F,Nixdorf S,Hacker NF,Heinzelmann-Schwarz VA

    更新日期:2014-06-07 00:00:00

  • Locally existing endothelial cells and pericytes in ovarian stroma, but not bone marrow-derived vascular progenitor cells, play a central role in neovascularization during follicular development in mice.

    abstract:BACKGROUND:Neovascularization is necessary for follicular growth. Vascularization is first observed in preantral follicles, and thereafter the vasculature markedly increases in follicles undergoing development. Neovascularization includes angiogenesis and vasculogenesis. Vasculogenesis is the formation of new blood ves...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/1757-2215-7-10

    authors: Kizuka-Shibuya F,Tokuda N,Takagi K,Adachi Y,Lee L,Tamura I,Maekawa R,Tamura H,Suzuki T,Owada Y,Sugino N

    更新日期:2014-01-21 00:00:00

  • S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin.

    abstract:BACKGROUND:Ovarian cancer is the leading cause of gynecological cancer-related mortality. The novel oncogene S100A10 has been reported to be involved in cancer cell proliferation, invasion and metastasis. The role of S100A10 in ovarian cancer has not been well studied and the effect of S100A10 on chemotherapy remains u...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-019-0592-3

    authors: Wang L,Yan W,Li X,Liu Z,Tian T,Chen T,Zou L,Cui Z

    更新日期:2019-11-18 00:00:00

  • Canine ovarian gonadoblastoma with dysgerminoma overgrowth: a case study and literature review.

    abstract:BACKGROUND:Gonadoblastoma (GB) is a rare mixed germ cell-sex cord-stromal tumour, first described in humans, commonly found in dysgenetic gonads of intersex patients that have a Y chromosome. However, this entity in not recognized in the WHO classification of tumours of genital system of domestic animals. Herein, we de...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-019-0561-x

    authors: Flores AR,Lobo J,Nunes F,Rêma A,Lopes P,Carvalho L,Bartosch C,Amorim I,Gärtner F

    更新日期:2019-09-23 00:00:00

  • The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer.

    abstract:BACKGROUND:Ovarian cancer (OVC) is the deadliest of all gynecologic cancers, primarily as a consequence of asymptomatic progression. The complex nature of OVC creates challenges for early detection, and there is a lack of specific and sensitive biomarkers suitable for screening and detecting early stage OVC. METHODS:P...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-016-0228-9

    authors: Tamir A,Gangadharan A,Balwani S,Tanaka T,Patel U,Hassan A,Benke S,Agas A,D'Agostino J,Shin D,Yoon S,Goy A,Pecora A,Suh KS

    更新日期:2016-03-31 00:00:00

  • Transparency in ovarian cancer clinical trial results: ClinicalTrials.gov versus PubMed, Embase and Google scholar.

    abstract:BACKGROUND:In recent years the question of the lack of transparency in clinical research has been debated by clinicians, researchers, citizens and their representatives, authors and publishers. This is particularly important for infrequent cancers such as ovarian cancer, where treatment still gives disappointing result...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-018-0404-1

    authors: Roberto A,Radrezza S,Mosconi P

    更新日期:2018-04-10 00:00:00

  • Follicular Fluid redox involvement for ovarian follicle growth.

    abstract::As the human ovarian follicle enlarges in the course of a regular cycle or following controlled ovarian stimulation, the changes in its structure reveal the oocyte environment composed of cumulus oophorus cells and the follicular fluid (FF).In contrast to the dynamic nature of cells, the fluid compartment appears as a...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章,评审

    doi:10.1186/s13048-017-0342-3

    authors: Freitas C,Neto AC,Matos L,Silva E,Ribeiro Â,Silva-Carvalho JL,Almeida H

    更新日期:2017-07-12 00:00:00

  • A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: a Canadian perspective.

    abstract::Currently, the world is in the seventh month of the COVID-19 pandemic. Globally, infections with novel SARS-CoV-2 virus are continuously rising with mounting numbers of deaths. International and local public health responses, almost in synchrony, imposed restrictions to minimize spread of the virus, overload of health...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章,评审

    doi:10.1186/s13048-020-00737-1

    authors: Madjunkov M,Dviri M,Librach C

    更新日期:2020-11-27 00:00:00

  • MiRNA-802 suppresses proliferation and migration of epithelial ovarian cancer cells by targeting YWHAZ.

    abstract:BACKGROUND:The imbalance of expression of microRNA-802 may have a significant place in tumor progression. However, the bio-function of epithelial ovarian cancer cells remains unclear. Therefore, we setup this study to explore the pathogenesis of epithelial ovarian cancer based on microRNA-802. METHODS:RT-qPCR analysis...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-019-0576-3

    authors: Yang B,Sun L,Liang L

    更新日期:2019-10-22 00:00:00